-
Evaluating the Reliability of Value of Information Methods: A Simulation-Based Comparison
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
Is Protocolized Stopping Lifelong Therapy With Eculizumab With Disease Monitoring and Retreatment for Eligible Atypical Hemolytic Uremic Syndrome (aHUS) Patients Cost-Effective? An Economic Evaluation of the SETS aHUS Trial
Sep 9, 2025, 16:22 PM -
Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting
Sep 9, 2025, 16:22 PM -
Advancing Target Trial Emulation With Synthetic Data: The Target Trial Optimization Framework
Sep 9, 2025, 16:22 PM -
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
From the Outside Looking in: Patient Advocacy Groups' and Healthcare Providers' Perspectives on Patient Engagement Strategies in the Israeli Health Technology Assessment Process
Sep 9, 2025, 16:22 PM -
Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country
Sep 9, 2025, 16:22 PM -
Zoom Out: Simplifying Complex Health Economic Model Structure Through Artificial Intelligence
Sep 9, 2025, 16:22 PM -
Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland
Sep 9, 2025, 16:22 PM -
Recognizing the Full Value of Novel Antibiotics: Identifying Value Elements in the Context of Antimicrobial Resistance
Sep 9, 2025, 16:22 PM -
Potential Operational Efficiencies of a Combination Influenza and COVID-19 Vaccine in US Pharmacies
Sep 9, 2025, 16:22 PM -
Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products
Sep 9, 2025, 16:22 PM -
Systems Simulation Methods for the Economic Evaluation of Non-Medicines and Nonsurgical Interventions: A Systematic Literature Review of Quality and Methods for Reproducing Complexity in Health and Health Behaviors
Sep 9, 2025, 16:22 PM -
Patient-Reported Outcomes After Total Knee Arthroplasty: Comparisons Across TKA Procedures and PRO Domains
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of a Robotic-Assisted Solution vs. a Manual Approach in Total Knee Arthroplasty in the UK
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment On Healthcare Resource Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Evaluate the Statistical Utility After Transformation of a CDISC SDTM Database Into OMOP CDM
Sep 9, 2025, 16:22 PM
